For COVID‐19 research, this includes rapid research funding opportunities with streamlined application processes, self‐funded research, fast‐tracked clinical trials, and research studies being ...completed in a fraction of the normal time. Hematologists and scientists in the thrombosis, hemostasis, and vascular biology fields are front and center in this science owing to the sinister coagulopathy associated with severe acute respiratory syndrome coronavirus 2 infection. 1 At Research and Practice in Thrombosis and Haemostasis (RPTH), we instituted measures to ease author stress during the pandemic, and to provide rapid dissemination of scientific and clinical information. 2 This includes science related to COVID‐19 and our “usual” science. Author gender for published articles in 2018‐19 (blue), submitted articles during March‐May in 2019 (orange) and 2020 (red), and COVID‐19–related articles in 2020 (yellow) To summarize the above results, the COVID‐19 stay‐at‐home months did not result in a reduction of women authors participating in publishing in RPTH.
...the JCI can be considered a more stable metric than the impact factor, and it accounts for early and later citations. First is expanded research on topics such as repurposing anticoagulant and ...other antithrombotic medications for nonthrombosis indications (including other infectious diseases perhaps), improved methods to identify medical patients at risk of thrombosis, and expanded basic and translational research on the roles of hemostatic and thrombotic pathways in organ failure syndromes (especially lung, heart, liver, and kidney), brain health, and aging phenotypes. ...interest in coagulopathies has increased among nonhematologists involved in COVID-19 care and research.
Many readers may be aware that the US Supreme Court looks like it will reverse precedent set 49 years ago (when I was a 9-year-old girl) in the Roe v Wade decision, which ruled in a 7-2 bipartisan ...decision that the Constitution of the United States protects a person's liberty to choose to have a therapeutic abortion without excessive government restriction. Among women who have therapeutic abortion, 62% are younger than age 30 years (12% are teens) and 49% live in poverty 2; these women will have far less access. ...the ruling will profoundly worsen socioeconomic based disparities in women's health that are already prominent in the United States. Increased representation Research and Practice in Thrombosis and Haemostasis 51 Yes 55 Yes Journal of Thrombosis and Haemostasis 19 No 50 No Blood 37 Yes 45 Yes Arteriosclerosis, Thrombosis, and Vascular Biology 25 No 39 No Journal of the American Heart Association 33 No 37 No Thrombosis Research 26 1 each 34 1 each Similar representation The Lancet Haematology 64 Yes 62 Yes American Journal of Hematology 53 No 54 No Haemophilia a 32 No 34 No British Journal of Haematology 23 No 23 No Thrombosis and Haemostasis 18 No 19 No Journal of Thrombosis and Thrombolysis 14 No 16 No Decreased representation Platelets 35 No 26 No Circulation 27 No 24 No European Journal of Haematology 21 No 14 No Note: Teams include editor, deputy or associate editors, and editorial board members.
The State-of-the-Art series includes reviews by experts presenting in State-of-the-Art sessions at the annual ISTH Congress and each article includes a “Congress Report” of interesting abstracts ...presented. If the article fits within the scope of the theme and is accepted following peer review, the APC will be waived. The first theme was “Psychological and Quality of Life/Functional Aspects of Thrombosis and Hemostasis Disorders,” and this call was closed early because of its success.
Longitudinal trend in percentage of women authors, overall and for invited articles, and by author type; Research and Practice in Thrombosis and Haemostasis, 2017‐19. Similar numbers of men and women ...have articles still in progress. Since there was no gender disparity in acceptance of invitations or withdrawal of invited articles, increasing the number of invitations to women is the best first step to improving the gender diversity of invited articles. ...we hope to implement a process to request information from authors, peer reviewers, and editorial board members to confidentially report gender and race/ethnicity so we have accurate information.
Goodbye 2020, hello to our future Cushman, Mary
Research and practice in thrombosis and haemostasis,
January 2021, Volume:
5, Issue:
1
Journal Article
Peer reviewed
Open access
The 300 000+ deaths from COVID‐19 in the United States (now) 1 provide stark illustration of the well‐known fact that despite great wealth, and that we spend more than any other country on health ...care when compared to other high‐income nations, for decades we have ranked near the bottom in several metrics of health starting from birth. 5 There are myriad reasons, including sexism, implicit bias, and structural racism. ...the National Heart, Lung, and Blood Institute selected researchers to collaborate on antithrombotic trials based on submitted letters of intent and research progress over the first months of the pandemic, forming the Accelerating COVID‐19 Therapeutic Interventions and Vaccines (ACTIV)‐4 program. At Research and Practice in Thrombosis and Haemostasis, we waived article publication charges and published original COVID‐19 research and articles that raise hypotheses relevant to treatment. 9 We studied the authorship gender gap during the first COVID wave 10 and published articles on new ways to disseminate science. 11 Dobson and Wolberg eloquently discussed scientific silver linings of COVID‐19 and considered the impact on institutional racism and increasing diversity in science. 4 I call on you to continue to submit science to us; we are also interested in Forum articles on the social impact of COVID‐19 and the events of 2020.
A proposal for staging COVID‐19 coagulopathy Thachil, Jecko; Cushman, Mary; Srivastava, Alok ...
Research and practice in thrombosis and haemostasis,
July 2020, Volume:
4, Issue:
5
Journal Article
Peer reviewed
Open access
Coronavirus disease 2019 (COVID‐19) is associated with significant hypercoagulability. However, despite prophylactic anticoagulation, critically ill patients with this condition develop thromboses. ...This forum discusses the lungs as the epicenter for the hemostatic issues, puts forward a proposal for staging COVID‐19 coagulopathy based on available diagnostic markers, and suggest considering current and future treatment options based on these different stages.
RPTH provides rigorous, rapid peer review and immediate dissemination of research reports from basic, clinical, translational and population or public health science. Align with the ISTH Strategic ...Plan Promote multidisciplinary science Seek articles on quality, outcomes and systems of care Promote open access data Promote digital discussion, including of preliminary findings Help authors use color effectively in figures Promote career development of early career editorial board members and associate editors Provide education on peer review Provide feedback and recognition of peer review excellence Increase awareness of ISTH and thrombosis and hemostasis science via social media Be closely connected to the ISTH Congresses Where did things start? “ISTH-Communications” Many of these elements are being achieved and some are still works in progress. Journal Cover Selection By this time a launch marketing timeline was developed, an introductory editorial was published in JTH, editorial board nominations were sought from ISTH leaders, a video was created, website was designed and the ScholarOne submission site was designed.
PDF
